News

The European supplement industry has transformed from a niche market serving fitness enthusiasts and health-conscious individuals into a mainstream economic powerhouse. Worth billions of euros and continuing its upward trajectory, this sector has become an integral component of Europe's...

Sanofi and Earendil Labs have announced a strategic collaboration effort that goes on to apply the discovery platform from Earendil across many of the Sanofi autoimmune and inflammatory disease programs. The two AI-powered research and development platforms from Earendil Labs concerning protein therapeutics go on...

Insilico Medicine has gone ahead with a multi-year research and development - R&D collaboration with Servier, of almost $888m, in order to develop and discover certain new oncology therapies. The partnership combines the AI drug discovery platforms of Insilico...

Johnson & Johnson - J&J has completed the acquisition of Halda Therapeutics which is a clinical-stage biotechnology firm for an amount of $3.05bn in cash. This move goes on to bring the Regulated Induced Proximity Targeting Chimera -RIPTAC platform from Halda to...

Celltrion on January 02, 2026, announced that it has completed the transfer of the biopharmaceutical production facility of Eli Lilly that’s located in Branchburg, New Jersey, and is now entering full-scale contract manufacturing operations - CMO when it comes...

In the most recent of a string of announcements ahead of the holiday season, Centers for Medicare & Medicaid Services (CMS) has unveiled a new voluntary access programme which aims to widen the usage of GLP-1 agonist medicines when it...

NICE has gone ahead and cleared the way for bevacizumab to be used by NHS in order to treat colorectal cancer for the very first time, all thanks to the availability when it comes to the lower-cost biosimilar versions...